SARS-CoV-2 infection in severe pediatric Crohn's disease. What about anti-tumor necrosis factor &#945; therapy?

Bardasi, Giulia; Alvisi, Patrizia

SARS-CoV-2 infection in severe pediatric Crohn's disease. What about anti-tumor necrosis factor α therapy?

Bardasi, Giulia; Alvisi, Patrizia.

Bardasi G; Department of Pediatrics, University of Bologna, Sant'Orsola-Malpighi Hospital, Bologna, Italy.
Alvisi P; Pediatric Gastroenterology Unit, Maggiore Hospital, Bologna, Italy. Electronic address: patrizia.alvisi@ausl.bologna.it.

Dig Liver Dis ; 52(11): 1244-1245, 2020 11.

Article in English | MEDLINE | ID: covidwho-640235

Subject(s)

Adalimumab/administration & dosage; Anti-Inflammatory Agents/administration & dosage; Coronavirus Infections/complications; Crohn Disease/complications; Crohn Disease/drug therapy; Pneumonia, Viral/complications; Adalimumab/adverse effects; Adolescent; Anti-Inflammatory Agents/adverse effects; Betacoronavirus; COVID-19; Coronavirus Infections/diagnosis; Coronavirus Infections/drug therapy; Female; Humans; Pandemics; Pneumonia, Viral/diagnosis; Pneumonia, Viral/drug therapy; Recurrence; SARS-CoV-2; Tumor Necrosis Factor-alpha/antagonists & inhibitors

Keywords

Biological therapy; Covid-19; Pediatric inflammatory bowel disease

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Crohn Disease / Coronavirus Infections / Adalimumab / Anti-Inflammatory Agents Type of study: Case report / Diagnostic study Topics: Long Covid Limits: Adolescent / Female / Humans Language: English Journal: Dig Liver Dis Journal subject: Gastroenterology Year: 2020 Document Type: Article Affiliation country: J.dld.2020.06.047

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google